Dr Anissa Widjaja, a senior research fellow at Duke-NUS’ Cardiovascular and Metabolic Disorders Programme, with Professor Stuart Cook, the programme’s director. Duke-NUS Medical School, National Heart Centre Singapore and biotechnology company Enleofen Bio collaborated on a study that could lead to a remedy for a severe form of non-alcoholic fatty liver disease. PHOTO: LIANHE ZAOBAO
Dr Anissa Widjaja, our SBS alumni and currently a senior research fellow at the Duke-NUS’ Cardiovascular and Metabolic Disorders Programme, was recently featured in The Straits Times.
She is part of the team comprising of researchers from the Duke-NUS Medical School, National Heart Centre Singapore and biotechnology company Enleofen Bio, collaborating on a study that could lead to a remedy for a severe form of non-alcoholic fatty liver disease.
Read the full article in The Straits Times here: https://www.straitstimes.com/…/local-researchers-working-on…